Post Wed Oct 23, 2019 3:19 pm

2019-Wei et al-Proc Natl Acad Sci U S A

"Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies"
Wei SC, Anang NAS, Sharma R, Andrews MC, Reuben A, Levine JH, Cogdill AP, Mancuso JJ, Wargo JA, Pe'er D, Allison JP
Proc Natl Acad Sci U S A. 2019
https://doi.org/10.1073/pnas.1821218116

New data:
Mouse TIL: FR-FCM-ZYQQ
Human peripheral blood: FR-FCM-ZYQR

Previous data: FR-FCM-ZY9M (Lavin et al Cell 2017)